Improving participation of Hispanic colorectal cancer patients in cancer genomics
USC PE-GCS: Optimizing Engagement of Hispanic Colorectal Cancer Patients in Cancer Genomic Characterization Studies
This project develops better ways to recruit, consent, and support Hispanic colorectal cancer patients so their genomic information is fairly represented.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Southern California NIH-funded |
| Lab location | 1 site (Los Angeles, UNITED STATES) |
| Project ID | NIH-11192759 on NIH RePORTER |
What this research studies
You would be part of efforts led by the USC Center for Optimization of Participant Engagement in Cancer Characterization (COPECC) to make it easier for Hispanic patients to join and stay in cancer genomics work. The team will create culturally and linguistically tailored outreach, consent, and follow-up approaches with input from community partners and clinics. Participants may be asked to share health information and biospecimens so genomic data can be linked to clinical outcomes. The center will track which methods improve enrollment and retention and share results back with participants and communities.
Who could benefit from this research
Good fit: Hispanic or Latinx adults with colorectal cancer, especially those with early-onset disease or adverse clinical outcomes, who can provide clinical information and biospecimens are ideal candidates.
Not a fit: People without colorectal cancer, those unwilling to share health data or samples, or those unable to participate due to language or distance are unlikely to directly benefit from this project.
Why it matters
Potential benefit: If successful, more Hispanic patients would be included in colorectal cancer genomics, which could lead to fairer access to precision medicine and better understanding of disease drivers.
How similar studies have performed: Community-engaged and culturally tailored recruitment efforts have improved participation in other genomics projects, but targeted work for Hispanic colorectal cancer patients is still relatively limited.
Where this research is happening
Los Angeles, UNITED STATES
- University of Southern California — Los Angeles, United States (Active)
Researchers
- Principal investigator: Lenz, Heinz Josef — University of Southern California
- Study coordinator: Lenz, Heinz Josef
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.